Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Parkinson Disease in United States

252 results

Sort By:

Comparing Antipsychotic Medications in LBD Over Time

Study ID: NCT05590637
Start Date: 2022-04-22
End Date: 2027-02
Study Type

Interventional

Study Phase

Phase4

No. of Participants

94

Intervention / Treatment

Pimavanserin

Quetiapine

Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Study ID: NCT04373317
Start Date: 2022-10-24
End Date: 2027-08-24
Study Type

Interventional

Study Phase

Phase4

No. of Participants

358

Intervention / Treatment

Pimavanserin

Quetiapine

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Robotic Gait Rehabilitation in Parkinson's Disease

Study ID: NCT05218187
Start Date: 2022-01-10
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

G-EO End-Effector Gait Trainer

Conventional Physical Therapy Treatment

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

Study ID: NCT05982730
Start Date: 2023-11-08
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Sensory-Augmented Postural Training

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

Study ID: NCT06508801
Start Date: 2025-01-07
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Blood flow restriction training

Instability Resistance Training

Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

Sensory-specific Peripheral Stimulation for Tremor Management

Study ID: NCT04501133
Start Date: 2020-09-01
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Peripheral electrical stimulation

Single pulse TMS

Sponsor

Shirley Ryan AbilityLab

Source: clinicaltrials.gov

Share:
Add to list

Telehealth in Lewy Body Dementia

Study ID: NCT05014971
Start Date: 2022-02-28
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

106

Intervention / Treatment

Tele-neurohub

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

Study ID: NCT04938817
Start Date: 2021-08-19
End Date: 2029-12-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

110

Intervention / Treatment

coformulation pembrolizumab/quavonlimab

lenvatinib

MK-4830

coformulation favezelimab/pembrolizumab

R-DXd

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease

Study ID: NCT06804668
Start Date: 2025-02-06
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6

Intervention / Treatment

tDCS

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Natural History Study of Synucleinopathies

Study ID: NCT01799915
Start Date: 2011-06
End Date: 2026-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment
Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list